Carboplatin Inhibits the Progression of Retinoblastoma Through IncRNA XIST/miR-200a-3p/NRP1 Axis
Author:
Zhao Hong,Wan Jingjing,Zhu Yu
Subject
Drug Discovery,Pharmaceutical Science,Pharmacology
Reference26 articles.
1. Xiao J, Ma M, Liang Ming, et al. [Site-directed mutagenesis of long gene by partial amplification combining with double fragments ligation]. Sheng Wu Gong Cheng Xue Bao. 2020;36:1232–1240.
2. MicroRNAs in retinoblastoma: Potential diagnostic and therapeutic biomarkers
3. Singh L, Singh MK, Rizvi MA, et al. Clinical relevance of the comparative expression of immune checkpoint markers with the clinicopathological findings in patients with primary and chemoreduced retinoblastoma. Cancer Immunol. Immunother. 2020;69:1087–1099.
4. Jiménez I, Laé M, Tanguy M, et al. Craniofacial second primary tumors in patients with germline retinoblastoma previously treated with external beam radiotherapy: A retrospective institutional analysis. Pediatr Blood Cancer. 2020;67:e28158.
5. The University of California, San Francisco Documentation System for Retinoblastoma: Preparing to Improve Staging Methods for This Disease
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献